Edition:
United States

Pulse Health Ltd (PHG.AX)

PHG.AX on Australia Stock Exchange

0.46AUD
28 Mar 2017
Change (% chg)

$0.00 (+0.55%)
Prev Close
$0.46
Open
$0.46
Day's High
$0.46
Day's Low
$0.46
Volume
128,488
Avg. Vol
460,359
52-wk High
$0.47
52-wk Low
$0.20

Latest Key Developments (Source: Significant Developments)

ACCC decided not to oppose Healthe Care Australia's acquisition of Pulse Health
Wednesday, 22 Mar 2017 06:26pm EDT 

Australian Competition and Consumer Commission: Decided not to oppose Healthe Care Australia's proposed acquisition of Pulse Health . Found although Mayo and Forster are only private hospitals in Forster-Taree region, 2 hospitals do not compete closely to attract doctors and patients .ACCC's review also considered potential for Healthe Care to use acquisition of Pulse to increase bargaining power in negotiations with private health insurance funds.  Full Article

Pulse Health updates on scheme implementation deed with Healthe Care Australia
Wednesday, 8 Mar 2017 05:50pm EST 

Pulse Health Ltd : Asx alert-scheme of arrangement update-phg.ax . "As at date of this announcement, ACCC's public consultation and review of proposed transaction is continuing" . "ACCC had specified 16 march 2017 as provisional date by which it intends to make a decision" .Pulse is hopeful of Healthe Care obtaining nz oio approval prior to date of scheme meeting scheduled for 22 march 2017.  Full Article

Pulse Health reaffirms guidance of FY17 underlying ebitda for established hospitals and day surgeries
Monday, 27 Feb 2017 07:17pm EST 

Pulse Health Ltd : Company reaffirms guidance of FY17 underlying EBITDA for established hospitals and day surgeries to be between $13.5m and $15.5m ."EBITDA ramp-up losses associated with gold coast surgical hospital are expected to be c.$4.5m in FY17 with profitability expected in FY18.".  Full Article

Pulse Health reaffirms guidance of FY17 underlying ebitda for established hospitals and day surgeries
Monday, 27 Feb 2017 06:02pm EST 

Pulse Health Ltd : Company reaffirms guidance of FY17 underlying EBITDA for established hospitals and day surgeries to be between $13.5m and $15.5m ."EBITDA ramp-up losses associated with gold coast surgical hospital are expected to be c.$4.5m in FY17 with profitability expected in FY18.".  Full Article

Pulse Health enters into binding scheme implementation deed with Healthe Care
Tuesday, 29 Nov 2016 07:53pm EST 

Pulse Health Ltd : Healthe care acquisition proposal-phg.ax . Pulse Health Group recommends $0.47 per share cash acquisition proposal from Healthe Care . Announces that it has entered into a binding scheme implementation deed with Healthe Care Australia Pty Ltd . Deal for a cash consideration of $0.47 per share . Board unanimously recommends, in absence of a superior proposal, that shareholders vote in favour of scheme .Major shareholder, viburnum funds pty ltd as trustee for vf strategic equities fund informed co it intends to vote in favour of scheme.  Full Article

Pulse Health enters into binding scheme implementation deed with Healthe Care
Tuesday, 29 Nov 2016 06:20pm EST 

Pulse Health Ltd : Healthe care acquisition proposal-phg.ax . Pulse Health Group recommends $0.47 per share cash acquisition proposal from Healthe Care . Announces that it has entered into a binding scheme implementation deed with Healthe Care Australia Pty Ltd . Deal for a cash consideration of $0.47 per share . Board unanimously recommends, in absence of a superior proposal, that shareholders vote in favour of scheme .Major shareholder, viburnum funds pty ltd as trustee for vf strategic equities fund informed co it intends to vote in favour of scheme.  Full Article

Pulse Health clarifies on speculation over corporate activity
Sunday, 24 Jul 2016 06:57pm EDT 

Pulse Health Ltd : Speculation of corporate activity . Notes the article in the Australian Financial Review on Friday 22 July 2016 . Article indicating that interests associated with Ben Thynne And Andrew Savage acquired between 10 percent and 11 per cent of the shares in Pulse . "Pulse understands this to be correct" . Received confidential indicative proposals and expressions of interest from other parties relating to acquisition of control of Pulse . Board has not pursued confidential proposals and expressions of interest further . Says confidential proposals and expressions of interest "fundamentally undervalued Pulse" . "Shareholders are advised to take no action in response to the media speculation" .  Full Article

Pulse Health announces termination of WA Asset acquisitions
Sunday, 19 Jun 2016 08:34pm EDT 

Pulse Health Ltd : Termination of wa asset acquisitions . Wa assets were expected to deliver $1.6 million of the incremental FY 2017 EBITDA of $6.4 million from acquisitions announced on 7 December 2015 .  Full Article

Pulse Health updates on outlook
Tuesday, 24 May 2016 06:33pm EDT 

Pulse Health Ltd : Expects FY 2016 underlying EBITDA of between $8.0 - 9.2 million from existing assets . Reduction in earnings is primarily attributable to a recent downturn in activity in our three rehabilitation hospitals . Revised guidance excludes any FY 2016 contributions from recently announced acquisitions . Says expects rehabilitation revenue to comprise less than 30% of group revenue in FY 2017, down from 57% in FY 2015. . Says expected to deliver an incremental FY 2017 EBITDA of $6.4 million . Total ramp-up losses (EBITDA level) are expected to be $6.0 million for FY 2016 (ifrs accounting basis). .  Full Article

Pulse Health acquires six Australian facilities and New Zealand hospital
Sunday, 6 Dec 2015 06:05pm EST 

Pulse Health:Acquires six Australian facilities and New Zealand hospital.Says Pulse Health Limited acquires six Australian facilities and one New Zealand hospital and provides pro forma FY 2017 EBITDA guidance of $18.1M.Says upfront consideration of $48.3 million and potential earn outs subject to FY 2016 and FY 2017 performance.Pulse reconfirms FY 2016 EBITDA guidance of $10.2M and provides pro forma FY 2017 EBITDA guidance of $18.1M.Fully underwritten $11.5 million share placement and a 2-for-5 pro rata non-renounceable entitlement offer to raise an additional $31.0 million at $0.470 per share.Pulse expects the acquisitions FY 2016 earnings impact on Pulse will be minimal.  Full Article

More From Around the Web